The presentation reviews EONs structure activity, the potential of the Axiomer platform as well as its applicability for the treatment of liver originated disorders. Presented at TIDES USA on May 9, 2023 by Gerard Platenburg - ProQR Therapeutics.
Progress on Development of RNA Base Editing Technologies for Precision Medicines, including Axiomer® platform presented at TIDES EU by Gerard Platenburg - ProQR Therapeutics
… ProQR will focus exclusively on the development of the Axiomer® RNA editing technology platform across multiple … ProQR will focus exclusively on the development of the Axiomer® RNA editing technology platform across multiple …
Development of RNA Base Editing Technologies for Precision Medicines with Axiomer® and Trident® presented at TIDES USA 2022 by Gerard Platenburg - ProQR Therapeutics.
… focuses on developing potential medicines using our Axiomer™ RNA editing platform technology. Strategic … drive the advancement of an early-stage technology, like Axiomer , closer to the clinic. In any global licensing and …
This presentation reviews Axiomer editing oligonucleotides (EONs) structure activity, the potential of Axiomer platform as well as its applicability for the treatment of liver originated disorders.
… Oligonucleotides to Address Liver Originated Disorders Axiomer platform presentation highlighting the potential of … and is currently in charge of our Innovation unit. Axiomer ® , an RNA editing platform, uses chemically modified … and the presentation will review the potential of Axiomer platform in multiple organs as well as its …
